Search

everythinglearnresearchcommunity

for

Search:↓

Autologous Micrografting Technology effectively improves hair growth and is a safe, promising option for hair restoration.

Current treatments for androgenetic alopecia are complex and promising, but more research is needed.

PLLA dermal fillers can cause hair loss, but it can be treated with steroids.

Trichoscopy helps diagnose and manage different types of hair loss in the Indian population.

ITK inhibitors may effectively treat alopecia areata.

The patient was diagnosed with oral lichen sclerosus and needs long-term monitoring.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Combining SVF cells with PRP may boost hair growth in androgenic alopecia.

Calcified epidermal cysts are rare, hard skin nodules that are best treated with surgical removal.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Gamma-irradiated amniotic fluid improves healing and reduces thickness of hypertrophic scars.

Sirtuin 1 could be a potential drug target for treating hypertrophic scars.

Scleroderma patients have lower hair miR-29a levels.

Human pluripotent stem cells could be used to make platelets for medical use, but safety, effectiveness, and cost issues need to be resolved.

A microneedle patch with curcumin and stem cell components effectively treats hypertrophic scars and promotes healing.

Hair can regrow after significant damage through a process similar to how it forms before birth, involving stem cells and various cell types and signals. This could be a new way to prevent scarring and promote hair growth.

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

Abnormal ECM and immune cell interactions can cause skin diseases.

HPDAlR nanoparticles greatly improve skin wound healing without toxicity.

MSC-derived exosomes may help in skin repair and regeneration.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Fibroblast and endothelial cell interactions are crucial in forming hypertrophic scars.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

PRP therapy shows promise for anti-aging but lacks consistent evidence and standardization.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.

Using Platelet-Rich Plasma and Adipose-Derived Mesenchymal Stem Cells together can improve healing, including wound healing, bone regeneration, and hair growth.

Congenital triangular alopecia is a hair loss condition present from birth or early childhood with no effective treatment needed.

Astragalus plants may improve skin health and have anti-aging benefits.

Bio-nanovesicles could improve hair and skin regeneration by delivering important molecules to repair and heal.